(1)What is the current level of collaboration between the Human Sciences Research Council (HSRC) and the SA National Space Agency (SANSA);
(2) Is the HSRC currently benefiting from prefential pricing from any of SANSA’s products and services with regard to (a) spatial development and migration, (b) HIV/AIDS and sexually transmitted diseases and (c) Tuberculosis; if not, why not in each case; if so, what are the relevant details of the specified benefits in each case?.”